GLP-1 Market
LLY $1306.69 ▲ +2.8% NVO $39.43 ▲ +0.9% PFE $30.42 ▲ +1.9% VKTX $25.83 ▼ -2.1% KLRA $13.27 ▲ +2.7% GPCR $21.93 ▼ -0.4% RHHBY $59.62 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ganciclovir Sodium

Company
City of Hope Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
24 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

24 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 23, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ganciclovir Sodium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01419561

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

    Not yet reported National Cancer Institute (NCI) 140 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8
    View official trial listing →
  • Recruiting NCT NCT03511118

    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

    Duke University 1600 participants Est. completion 2028-07-31 22 sites
    Other conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
    View official trial listing →
  • Recruiting NCT NCT04278404

    Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    Duke University 5000 participants Est. completion 2026-12 52 sites
    Heart failure Other conditions: Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema, Hypokalemia, Hemophilia, Menorrhagia, Insomnia, Pneumonia, Skin Infection, Arrythmia, Asthma in Children, Bronchopulmonary Dysplasia, Adrenal Insufficiency, Fibrinolysis; Hemorrhage, Attention Deficit Hyperactivity Disorder, Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coagulation Disorder, Down Syndrome
    View official trial listing →
  • Recruiting NCT NCT05234723

    Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 100 participants Est. completion 2028-02-28 23 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Recruiting NCT NCT05564598

    CMV CTLs in Neonates With CMV Infection

    Not yet reported New York Medical College 23 participants Est. completion 2028-10-31 4 sites Stand-alone
    Other conditions: Congenital Cytomegaloviral (CMV) Disease
    View official trial listing →
  • Recruiting NCT NCT05708755

    CMV Immunity Monitoring in Lung Transplant Recipients

    Not yet reported NYU Langone Health 50 participants Est. completion 2028-05 1 site
    Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT05911503

    Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

    Not yet reported Tianjin Medical University 15 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Cytomegalovirus Retinitis, Ganciclovir Eye Drops
    View official trial listing →
  • Recruiting NCT NCT06102525

    A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

    Not yet reported, Not yet reported Rznomics, Inc. 43 participants Est. completion 2029-05 6 sites Stand-alone
    Other conditions: Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT06334497

    Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2027-11 5 sites
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Recruiting NCT NCT06407232

    Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

    Not yet reported University of Wisconsin, Madison 90 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections, Kidney Transplant Infection, Pancreas Transplant
    View official trial listing →
  • Recruiting NCT NCT06436534

    Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Rhinitis, Allergic
    View official trial listing →
  • Recruiting NCT NCT06474442

    A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

    Not yet reported Shanghai BDgene Co., Ltd. 40 participants Est. completion 2027-03 1 site Stand-alone
    Other conditions: Herpes Simplex Virus Type I Stromal Keratitis
    View official trial listing →
  • Recruiting NCT NCT06555432

    A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

    Takeda 168 participants Est. completion 2028-10-01 1 site
    Other conditions: Cytomegalovirus (CMV)
    View official trial listing →
  • Recruiting NCT NCT06574789

    Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

    Not yet reported Murdoch Childrens Research Institute 232 participants Est. completion 2028-12 7 sites
    Other conditions: Cytomegalovirus Viraemia
    View official trial listing →
  • Recruiting NCT NCT06798909

    Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

    Not yet reported University of California, San Francisco 360 participants Est. completion 2031-05-31 8 sites
    Other conditions: Cytomegalovirus (CMV), Kidney Transplant; Complications, Kidney Diseases
    View official trial listing →
  • Recruiting NCT NCT06853184

    Study Evaluating the Efficacy and Safety of Artesunate

    Not yet reported Amivas Inc. 90 participants Est. completion 2028-06-30 4 sites
    Other conditions: CMV Infection
    View official trial listing →
  • Recruiting NCT NCT07079735

    Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

    Not yet reported, Not yet reported Columbia University 150 participants Est. completion 2029-01-17 2 sites
    Other conditions: CMV Viremia, Heart Transplant Infection, Heart Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT07235683

    Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

    Not yet reported University Health Network, Toronto 40 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: CMV, Lung Transplant Recipient
    View official trial listing →
  • Recruiting NCT NCT07266467

    Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 290 participants Est. completion 2026-11-30 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT07294547

    Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

    Not yet reported National Taiwan University Hospital 80 participants Est. completion 2030-12 1 site
    Other conditions: Kidney Transplantation, Cytomegalovirus Infections, EBV Infection, Antiviral Prophylaxis
    View official trial listing →
  • Recruiting NCT NCT07383649

    Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2030-05 1 site
    Other conditions: Brain Cancer Metastatic, CMV Viremia
    View official trial listing →
  • Recruiting NCT NCT07488728

    Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

    Not yet reported Beijing Children's Hospital 80 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: EBV-associated T/NK-cell Lymphoproliferative Diseases, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis, Letermovir
    View official trial listing →
  • Recruiting NCT NCT07499284

    A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

    Not yet reported The First Affiliated Hospital of Soochow University 224 participants Est. completion 2028-09-30 4 sites Stand-alone
    Other conditions: Aplastic Anaemia
    View official trial listing →
  • Recruiting NCT NCT07688759

    CMV-CMI in csCMVi After HSCT

    The First Affiliated Hospital of Soochow University 40 participants Est. completion 2028-08-31 1 site
    Other conditions: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation (HSCT), Immune Reconstitution
    View official trial listing →
  • Completed NCT NCT00000118

    Ganciclovir Implant Study for Cytomegalovirus Retinitis

    Not yet reported National Eye Institute (NEI) Est. completion 1993-12
    Other conditions: HIV Infections, Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis
    View official trial listing →
  • Completed NCT NCT00000134

    Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)

    Not yet reported Johns Hopkins Bloomberg School of Public Health 279 participants Est. completion 1995-03
    Other conditions: HIV Infections, Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis
    View official trial listing →
  • Completed NCT NCT00000136

    Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

    Not yet reported Johns Hopkins Bloomberg School of Public Health 234 participants Est. completion 1991-10 Stand-alone
    Other conditions: HIV Infections, Cytomegalovirus Retinitis
    View official trial listing →
  • Completed NCT NCT00000143

    Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)

    Not yet reported Johns Hopkins Bloomberg School of Public Health 61 participants Est. completion 2000-06 19 sites Stand-alone
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000665

    Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 240 participants 9 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000668

    A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 1995-02 5 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000673

    A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 38 participants Est. completion 1993-05 2 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000688

    A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 180 participants 22 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000691

    A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 156 participants Est. completion 1992-08 11 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Withdrawn NCT NCT00000697

    A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID)
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000698

    A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2007-08 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000766

    CMV Retinitis Retreatment Trial

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 300 participants 9 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000768

    A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 1998-08 5 sites
    Other conditions: Colitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000805

    A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 1998-03 19 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Withdrawn NCT NCT00000856

    A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID)
    Other conditions: Encephalopathy, HIV Infections, Radiculitis
    View official trial listing →
  • Completed NCT NCT00000894

    Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 300 participants 12 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000970

    A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 1993-06 6 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000989

    The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 1992-07 4 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000995

    A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 1990-02 3 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00001034

    The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 850 participants Est. completion 1995-08 17 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections, Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT00001061

    Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 167 participants Est. completion 1998-03 20 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00001062

    A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 1998-01 6 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00001100

    A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 130 participants Est. completion 2005-11 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00001328

    Gene Therapy for the Treatment of Brain Tumors

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 15 participants Est. completion 2010-04-30 1 site
    Other conditions: Brain Neoplasm, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00001999

    A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

    Not yet reported American National Red Cross 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002015

    An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

    Not yet reported Roche Global Development 20 participants 8 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002016

    A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

    Not yet reported Sandoz 2 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002024

    Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections

    Not yet reported Hoffmann-La Roche 1 site
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002025

    Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

    Not yet reported Hoffmann-La Roche 1 site
    Other conditions: Cytomegalovirus Infections, Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002034

    A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

    Not yet reported Hoffmann-La Roche 100 participants 9 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002070

    Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

    Not yet reported Schering-Plough 14 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002095

    A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus

    Not yet reported Hoffmann-La Roche 700 participants 19 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002096

    A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine

    Not yet reported Hoffmann-La Roche 24 participants 3 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002134

    A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis

    Not yet reported Roche Global Development 450 participants 23 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002135

    An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access

    Not yet reported Hoffmann-La Roche 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002156

    A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

    Not yet reported Ionis Pharmaceuticals, Inc. 194 participants 18 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002222

    A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

    Not yet reported Hoffmann-La Roche 200 participants 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002247

    A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

    Not yet reported Hoffmann-La Roche 225 participants 20 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002251

    A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir

    Not yet reported Hoffmann-La Roche 20 participants 2 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002257

    A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

    Not yet reported Hoffmann-La Roche 150 participants 13 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002273

    A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS

    Not yet reported Hoffmann-La Roche 1 site
    Other conditions: Colitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002299

    The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

    Not yet reported Hoffmann-La Roche 6 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Status unknown NCT NCT00002301

    A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

    Not yet reported Astra USA 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002321

    A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

    Not yet reported Chiron Corporation 1 site
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002330

    A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

    Not yet reported Roche Global Development 280 participants 36 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002377

    A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

    Not yet reported Hoffmann-La Roche Est. completion 2002-12 19 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002824

    Gene Therapy in Treating Patients With Primary Brain Tumors

    Not yet reported Abramson Cancer Center at Penn Medicine 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00004278

    Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection

    Not yet reported National Center for Research Resources (NCRR) 130 participants
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT00004573

    Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT00005025

    Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

    Not yet reported John Stoddard Cancer Center at Iowa Methodist Medical Center 1 site
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00005057

    Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

    Not yet reported National Human Genome Research Institute (NHGRI) 3 sites
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00006145

    Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2006-02 57 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Status unknown NCT NCT00006216

    Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

    Not yet reported Louisiana State University Health Sciences Center in New Orleans 1 site
    Other conditions: Malignant Mesothelioma
    View official trial listing →
  • Completed NCT NCT00006264

    Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

    Not yet reported AIDS Malignancy Consortium Est. completion 2003-07 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00006340

    Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

    Not yet reported Boston Medical Center Est. completion 2000-07 6 sites
    Other conditions: Leukemia, Lymphoma, Precancerous Condition, Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00006480

    Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-03 2 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00014911

    Islet Transplantation for Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 36 participants Est. completion 2010-08 9 sites Stand-alone
    Other conditions: Diabetes Mellitus, Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00016068

    Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 184 participants Est. completion 2007-09 7 sites
    Other conditions: Infection
    View official trial listing →
  • Status unknown NCT NCT00017784

    Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection

    Not yet reported Hoffmann-La Roche 500 participants 9 sites
    Other conditions: Cytomegalovirus Retinitis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00023231

    Pediatric Kidney Transplant Without Calcineurin Inhibitors

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2006-08 1 site Stand-alone
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00031421

    Neonatal CMV-Ganciclovir Follow-up Study

    National Institute of Allergy and Infectious Diseases (NIAID) 8 participants Est. completion 2005-11 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00031434

    Valganciclovir in Congenital CMV Infants

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2007-07 21 sites Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00034385

    Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients

    Not yet reported National Institutes of Health Clinical Center (CC) 12 participants Est. completion 2009-10-30 1 site
    Other conditions: Kidney Trasplant
    View official trial listing →
  • Completed NCT NCT00090766

    A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients

    Not yet reported, Not yet reported Hoffmann-La Roche 63 participants Est. completion 2005-05 17 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Active, not recruiting NCT NCT00092222

    Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

    Not yet reported National Cancer Institute (NCI) 75 participants Est. completion 2028-10-01 1 site
    Other conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV
    View official trial listing →
  • Terminated NCT NCT00093704

    Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma

    Not yet reported Jonsson Comprehensive Cancer Center 1 participants 1 site Stand-alone
    Other conditions: Lymphoma, Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT00096538

    Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

    Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2008-02 3 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00141037

    Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 130 participants Est. completion 2010-11 12 sites Stand-alone
    Other conditions: Kidney Diseases, Kidney Transplantation, Kidney Transplant, Renal Transplantation, Renal Transplant
    View official trial listing →
  • Completed NCT NCT00189150

    Pharmacokinetics of Mmf and Valganciclovir

    Not yet reported University of Michigan 16 participants Est. completion 2007-08 1 site
    Other conditions: Kidney Transplant Recipient, Heart Transplant Recipient
    View official trial listing →
  • Completed NCT NCT00194467

    Suppression of Oral HHV8 Shedding With Valganciclovir

    Not yet reported University of Washington 32 participants Est. completion 2005-03 1 site
    Other conditions: Human Herpesvirus 8
    View official trial listing →
  • Completed NCT NCT00214240

    The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease

    Not yet reported University of Wisconsin, Madison 28 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT00217503

    Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma

    Not yet reported National Cancer Institute (NCI) 15 participants Est. completion 2007-06 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00225394

    Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients

    University of Massachusetts, Worcester 100 participants Est. completion 2006-07 4 sites
    Other conditions: CMV Disease, Viral Resistance, Rejection, Death
    View official trial listing →
  • Completed NCT NCT00227370

    Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation

    Not yet reported Duke University 136 participants Est. completion 2008-12 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Terminated NCT NCT00237653

    MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus

    Not yet reported University Hospital, Grenoble 40 participants Est. completion 2007-12 1 site
    Other conditions: Cytomegalovirus Infections, Inflammatory Bowel Diseases
    View official trial listing →
  • Terminated NCT NCT00241345

    Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

    Not yet reported Washington University School of Medicine 39 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00264290

    Valganciclovir to Reduce T Cell Activation in HIV Infection

    Not yet reported University of California, San Francisco 30 participants Est. completion 2008-11 1 site
    Other conditions: HIV Infections, Cytomegalovirus Infections
    View official trial listing →
  • Terminated NCT NCT00264368

    Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy

    Not yet reported University of Oslo School of Pharmacy 6 participants Est. completion 2007-06 1 site
    Other conditions: Acute Renal Failure, Cytomegalovirus Infections, Multi Organ Failure
    View official trial listing →
  • Terminated NCT NCT00275314

    WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients

    Not yet reported University of Pittsburgh 5 participants Est. completion 2006-04 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00275665

    The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.

    Not yet reported Mayo Clinic 20 participants Est. completion 2007-07 1 site
    Other conditions: Bone Marrow Stem Cell Transplant
    View official trial listing →
  • Completed NCT NCT00294515

    IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients

    Not yet reported Hoffmann-La Roche 326 participants Est. completion 2009-08-31 80 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00330018

    Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

    Not yet reported Hadassah Medical Organization 40 participants Est. completion 2010-04 1 site
    Other conditions: Bone Marrow Transplantation, Cytomegalovirus
    View official trial listing →
  • Withdrawn NCT NCT00361933

    Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

    Not yet reported University of Washington Est. completion 2009-05
    Other conditions: Giant Lymph Node Hyperplasia
    View official trial listing →
  • Status unknown NCT NCT00364052

    Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients

    Oregon Health and Science University 200 participants Est. completion 2007-01
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00372229

    A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation

    Not yet reported Hoffmann-La Roche 299 participants Est. completion 2015-10 24 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00373165

    Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients

    Not yet reported Lower Saxony Center for Nephrology 150 participants Est. completion 2003-10
    Other conditions: DNA Virus Infection, Herpesviridae Infections, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT00374686

    Study of Prophylactic Vs Preemptive Valganciclovir

    Not yet reported Washington University School of Medicine 120 participants Est. completion 2005-09 1 site
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT00377741

    A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.

    Not yet reported Hoffmann-La Roche 31 participants Est. completion 2006-06 5 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00386412

    TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant

    Not yet reported PETHEMA Foundation 132 participants Est. completion 2009-09 8 sites
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Withdrawn NCT NCT00387530

    Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

    Not yet reported University of California, San Diego Est. completion 2008-01 1 site
    Other conditions: Gastric Cancer, Head and Neck Cancer, Lymphoma, Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT00400322

    Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

    Not yet reported Karolinska Institutet 42 participants Est. completion 2008-06 3 sites
    Other conditions: Glioblastoma Multiforme, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT00431353

    VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

    Not yet reported Hoffmann-La Roche 325 participants Est. completion 2008-08 50 sites Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00466817

    Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 109 participants Est. completion 2013-06 48 sites Stand-alone
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT00478465

    Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

    Not yet reported, Not yet reported Stanford University 30 participants Est. completion 2007-08 1 site
    Other conditions: Chronic Fatigue Syndrome
    View official trial listing →
  • Completed NCT NCT00497796

    Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

    Not yet reported Shire 307 participants Est. completion 2009-09-14 55 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00530218

    Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

    Not yet reported City of Hope Medical Center 61 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Leukemia, Lymphoma, Multiple Myeloma, MDS, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00562770

    Oral Valganciclovir Versus Valacyclovir

    Not yet reported M.D. Anderson Cancer Center 46 participants Est. completion 2006-07 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Leukemia
    View official trial listing →
  • Completed NCT NCT00566072

    The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

    Not yet reported University Hospital, Ghent 21 participants Est. completion 2003-05 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT00716911

    Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

    Not yet reported City of Hope Medical Center 100 participants Est. completion 2007-07
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonneoplastic Condition
    View official trial listing →
  • Completed NCT NCT00730769

    Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

    Not yet reported Salvador Gil-Vernet 21 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Status unknown NCT NCT00828503

    Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

    Not yet reported Marcus Saemann 40 participants Est. completion 2014-06 1 site
    Other conditions: Cytomegalovirus Disease
    View official trial listing →
  • Terminated NCT NCT00917826

    Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

    Not yet reported HemaQuest Pharmaceuticals Inc. 1 participants 1 site Stand-alone
    Other conditions: EBV Lymphomas, Lympho-proliferative Diseases
    View official trial listing →
  • Completed NCT NCT00947141

    Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

    Not yet reported University College, London 165 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Viraemia
    View official trial listing →
  • Completed NCT NCT00964756

    A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

    Not yet reported University of Alabama at Birmingham 11 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT00966836

    Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy

    Not yet reported University of Bologna 100 participants 1 site
    Other conditions: Heart Transplantation, Cardiac Allograft Vasculopathy, Cytomegalovirus Infection
    View official trial listing →
  • Status unknown NCT NCT00986557

    T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

    Not yet reported University Hospital Birmingham 78 participants 1 site
    Other conditions: Graft Versus Host Disease, Nonneoplastic Condition
    View official trial listing →
  • Terminated NCT NCT00992732

    Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

    Not yet reported HemaQuest Pharmaceuticals Inc. 1 participants 8 sites Stand-alone
    Other conditions: Lymphoid Malignancies, Lymphoproliferative Disorders
    View official trial listing →
  • No Longer Available NCT NCT01049633

    B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

    National Institute of Allergy and Infectious Diseases (NIAID) 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01077908

    Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

    Not yet reported Cell Medica Ltd 89 participants Est. completion 2014-10 14 sites Stand-alone
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT01156025

    Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis

    Not yet reported Laboratoires Thea 16 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Acute Adenoviral Keratoconjunctivitis
    View official trial listing →
  • Completed NCT NCT01165580

    A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age

    Not yet reported Hoffmann-La Roche 17 participants Est. completion 2013-09 19 sites
    Other conditions: Cytomegalovirus Infections, Heart Transplantation
    View official trial listing →
  • Terminated NCT NCT01185223

    Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation

    Not yet reported Pierrel Research Europe GmbH 212 participants 17 sites
    Other conditions: Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT01199562

    Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

    City of Hope Medical Center 153 participants Est. completion 2026-12-01 1 site
    Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, Blastic Phase Chronic Myelogenous Leukemia, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Cytomegalovirus Infection, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Splenic Marginal Zone Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01220895

    Alternate Donor Study of Pre-Emptive Cellular Therapy

    Not yet reported Cell Medica Ltd 52 participants Est. completion 2014-01 9 sites Stand-alone
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT01255644

    Antiviral Treatment of Chronic Lymphocytic Leukemia

    Not yet reported Medical University of Vienna 20 participants Est. completion 2015-07 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01329185

    Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

    Not yet reported University of Minnesota 17 participants Est. completion 2014-04 1 site
    Other conditions: EBV Viremia, CMV Viremia
    View official trial listing →
  • Completed NCT NCT01335932

    Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

    Not yet reported Fred Hutchinson Cancer Center 160 participants Est. completion 2016-10-28 14 sites Stand-alone
    Other conditions: Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
    View official trial listing →
  • Completed NCT NCT01349452

    Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis

    Not yet reported Federal University of São Paulo 33 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Conjunctivitis, Viral, Adenoviridae Infections
    View official trial listing →
  • Status unknown NCT NCT01359995

    Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis

    National Taiwan University Hospital 7 participants Est. completion 2011-11 1 site
    Other conditions: Cytomegalovirus Endotheliitis
    View official trial listing →
  • Completed NCT NCT01376804

    A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients

    Not yet reported Hoffmann-La Roche 57 participants Est. completion 2013-05-31 25 sites
    Other conditions: Kidney Transplantation, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01441063

    Tocilizumab for KSHV-Associated Multicentric Castleman Disease

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2020-10-05 1 site
    Other conditions: Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia
    View official trial listing →
  • Completed NCT NCT01446445

    Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

    Not yet reported Nuria Lloberas 60 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Infection in Solid Organ Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT01486693

    Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis

    National Taiwan University Hospital 60 participants Est. completion 2012-09 1 site
    Other conditions: Anterior Uveitis
    View official trial listing →
  • Completed NCT NCT01503918

    Cytomegalovirus Control in Critical Care

    Not yet reported University Hospital Birmingham NHS Foundation Trust 124 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Critical Illness
    View official trial listing →
  • Completed NCT NCT01509404

    Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

    Not yet reported Medical University of South Carolina 40 participants Est. completion 2015-12 1 site
    Other conditions: Cytomegalovirus Disease
    View official trial listing →
  • Completed NCT NCT01533480

    A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis

    Not yet reported Lifelong Vision Foundation 20 participants Est. completion 2016-04 1 site
    Other conditions: Keratoconjunctivitis Due to Adenovirus, Viral Shedding
    View official trial listing →
  • Completed NCT NCT01552369

    CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 205 participants Est. completion 2018-06-22 6 sites
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Status unknown NCT NCT01600365

    Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

    Not yet reported Adapt Produtos Oftalmológicos Ltda. 22 participants Est. completion 2012-06
    Other conditions: Conjunctivitis, Adenovirus.
    View official trial listing →
  • Completed NCT NCT01602614

    Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

    University of Alabama at Birmingham 18 participants Est. completion 2019-03 15 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01611974

    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

    Not yet reported Shire 120 participants Est. completion 2014-12-05 32 sites
    Other conditions: Cytomegalovirus (CMV)
    View official trial listing →
  • Completed NCT NCT01647529

    Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis

    Not yet reported Singapore National Eye Centre 29 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Cytomegalovirus Anterior Segment Infection, Anterior Uveitis, Endotheliitis
    View official trial listing →
  • Completed NCT NCT01649869

    Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 54 participants Est. completion 2019-12-24 18 sites
    Other conditions: Cytomegalovirus Infection
    View official trial listing →
  • Terminated NCT NCT01655212

    Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial

    Not yet reported Dr. Ann C.T.M. Vossen 2 participants Est. completion 2013-10 1 site
    Other conditions: Congenital Cytomegalovirus Infection, Sensorineural Hearing Loss
    View official trial listing →
  • Completed NCT NCT01663740

    A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls

    Not yet reported Hoffmann-La Roche 59 participants Est. completion 2016-12-30 19 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01972035

    ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

    Not yet reported University of Minnesota 137 participants Est. completion 2021-02-28 1 site
    Other conditions: Transplantation Infection, Epstein-Barr Virus Infections, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT02005822

    Congenital Cytomegalovirus: Efficacy of Antiviral Treatment

    Not yet reported Dr. Ann C.T.M. Vossen 37 participants Est. completion 2018-05-17 1 site
    Other conditions: Congenital Cytomegalovirus Infection, Sensorineural Hearing Loss
    View official trial listing →
  • Completed NCT NCT02152358

    PTH - Preemptive Treatment for Herpesviridae

    Not yet reported Assistance Publique Hopitaux De Marseille 317 participants Est. completion 2023-04-05 1 site
    Other conditions: Viral Pneumonia
    View official trial listing →
  • Terminated NCT NCT02188719

    Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-06-18 3 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02202564

    Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma

    Not yet reported Huazhong University of Science and Technology 81 participants Est. completion 2013-08 Stand-alone
    Other conditions: Liver Cancer, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02296723

    Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition

    Not yet reported Dr. Reddy's Laboratories Limited 66 participants Est. completion 2011-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02297854

    Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition

    Not yet reported Dr. Reddy's Laboratories Limited 83 participants Est. completion 2011-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02370758

    Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

    Not yet reported University Health Network, Toronto 32 participants Est. completion 2017-06-16 1 site
    Other conditions: Cytomegalovirus Viraemia
    View official trial listing →
  • Completed NCT NCT02376088

    Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease

    Weikai Hou 328 participants Est. completion 2014-06
    Other conditions: Graves Disease
    View official trial listing →
  • Terminated NCT NCT02382588

    Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

    Not yet reported Northwestern University 8 participants Est. completion 2020-05-11 1 site
    Other conditions: Herpes Zoster Keratitis
    View official trial listing →
  • Withdrawn NCT NCT02409147

    Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center

    Not yet reported University of Nebraska Est. completion 2018-07-24
    Other conditions: Uterus Transplant
    View official trial listing →
  • Terminated NCT NCT02439957

    A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

    Not yet reported Jazz Pharmaceuticals 6 participants Est. completion 2016-07-31 3 sites
    Other conditions: Cytomegalovirus Disease, Kidney Transplant Infection
    View official trial listing →
  • Terminated NCT NCT02439970

    A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

    Not yet reported Jazz Pharmaceuticals 5 participants Est. completion 2016-01-30 3 sites
    Other conditions: Cytomegalovirus Disease
    View official trial listing →
  • Completed NCT NCT02503982

    Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients

    Not yet reported Rabin Medical Center 13 participants Est. completion 2015-08 1 site
    Other conditions: Infection in Solid Organ Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02538172

    Cell-mediated Immunity for Prevention of CMV Disease

    Not yet reported University of Lausanne Hospitals 195 participants Est. completion 2021-01 5 sites
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Terminated NCT NCT02606266

    Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 1 participants Est. completion 2018-12-11 1 site
    Other conditions: Congenital Cytomegalovirus (CMV)
    View official trial listing →
  • Status unknown NCT NCT02761291

    Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

    Not yet reported Chang Gung Memorial Hospital 18 participants 1 site
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT02871401

    A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

    Not yet reported Vanderbilt University Medical Center 31 participants Est. completion 2020-01-31 1 site
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Completed NCT NCT02927067

    A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

    Not yet reported Shire 553 participants Est. completion 2022-07-01 129 sites
    Other conditions: Cytomegalovirus (CMV)
    View official trial listing →
  • Completed NCT NCT02931539

    Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

    Not yet reported Shire 352 participants Est. completion 2020-08-17 134 sites
    Other conditions: Cytomegalovirus (CMV)
    View official trial listing →
  • Completed NCT NCT02943057

    Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis

    Not yet reported Singapore National Eye Centre 25 participants Est. completion 2024-11-30 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02973464

    The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

    First Affiliated Hospital Xi'an Jiaotong University 450 participants Est. completion 2019-12 1 site
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT03004261

    CMV-CTL for the Treatment of CMV Infection After HSCT

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections, Hematological Disease
    View official trial listing →
  • Status unknown NCT NCT03088553

    Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment

    Rennes University Hospital 138 participants Est. completion 2024-06-21 1 site
    Other conditions: Solid Organ Transplantation
    View official trial listing →
  • Terminated NCT NCT03107871

    Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

    Not yet reported Albert Park 10 participants Est. completion 2022-08-31 30 sites
    Other conditions: Cmv Congenital, CMV, Congenital Cmv, SNHL, Sensorineural Hearing Loss
    View official trial listing →
  • Status unknown NCT NCT03113344

    Population Pharmacokinetics of Anti-infective Drugs in Children With Infectious Diseases

    Beijing Children's Hospital 800 participants Est. completion 2025-12-31 1 site
    Other conditions: Children; Infection
    View official trial listing →
  • Status unknown NCT NCT03217474

    Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

    Not yet reported Chunxiao Wang 100 participants Est. completion 2019-12-30 1 site Stand-alone
    Other conditions: Herpes Simplex Keratitis
    View official trial listing →
  • Completed NCT NCT03296553

    Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

    Not yet reported National Institute of Cancerología 40 participants Est. completion 2019-08-26 1 site
    Other conditions: Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome
    View official trial listing →
  • Terminated NCT NCT03301415

    Asymptomatic Congenital CMV Treatment

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 7 participants Est. completion 2020-11-05 9 sites
    Other conditions: Congenital Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT03339661

    Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.

    Not yet reported University Hospital, Bordeaux 38 participants Est. completion 2020-11-23 2 sites Stand-alone
    Other conditions: Kidney Transplant Infection
    View official trial listing →
  • Completed NCT NCT03397706

    Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies

    Not yet reported, Not yet reported Viracta Therapeutics, Inc. 64 participants Est. completion 2023-05-04 28 sites
    Other conditions: Epstein-Barr Virus-Associated Lymphoma, Lymphoproliferative Disorders
    View official trial listing →
  • Completed NCT NCT03443869

    Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)

    Not yet reported Merck Sharp & Dohme LLC 601 participants Est. completion 2022-04-05 94 sites
    Other conditions: CMV Disease
    View official trial listing →
  • Withdrawn NCT NCT03532035

    Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

    Not yet reported Jazz Pharmaceuticals Est. completion 2019-05-10 8 sites
    Other conditions: Adenovirus
    View official trial listing →
  • Terminated NCT NCT03586284

    Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

    Not yet reported, Not yet reported University of California, San Francisco 51 participants Est. completion 2024-11-13 4 sites
    Other conditions: Cytomegalovirus Anterior Uveitis
    View official trial listing →
  • Completed NCT NCT03598452

    High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

    Not yet reported Aier School of Ophthalmology, Central South University 33 participants Est. completion 2018-06 Stand-alone
    Other conditions: Infection Viral, Uveitis, Posterior
    View official trial listing →
  • Completed NCT NCT03631316

    Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

    Not yet reported Luis Eduardo Morales Buenrostro 8 participants Est. completion 2018-11-01 1 site
    Other conditions: Kidney Transplantation, Cytomegalovirus Infections, Pharmacokinetics, Therapeutic Equivalency
    View official trial listing →
  • Status unknown NCT NCT03698435

    (Val)Ganciclovir TDM in Transplant Recipients

    University Medical Center Groningen 100 participants Est. completion 2019-12-31 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT03699254

    Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

    Not yet reported Maimónides Biomedical Research Institute of Córdoba 150 participants Est. completion 2023-05-29 7 sites Stand-alone
    Other conditions: Transplantation Infection, Cytomegalovirus Infections
    View official trial listing →
  • Terminated NCT NCT03752372

    Microbiome Alterations in IL10RA-deficient Patients After HSCT

    Children's Hospital of Fudan University 13 participants Est. completion 2020-02-28 1 site
    Other conditions: Inflammatory Bowel Diseases, Microbiota
    View official trial listing →
  • Completed NCT NCT03915366

    Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

    Not yet reported, Not yet reported Hospital Universitario 12 de Octubre 563 participants Est. completion 2025-01-31 13 sites
    Other conditions: Pneumonia, HIV/AIDS, Tuberculosis, Cytomegalovirus Infections
    View official trial listing →
  • Terminated NCT NCT04064697

    Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 6 participants Est. completion 2024-02-08 8 sites
    Other conditions: Ulcerative Colitis, Unspecified
    View official trial listing →
  • Active, not recruiting NCT NCT04116411

    A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

    Not yet reported Cecilia Soderberg-Naucler 220 participants Est. completion 2027-09-16 3 sites
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Status unknown NCT NCT04132115

    Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

    Azienda Sanitaria-Universitaria Integrata di Udine 104 participants Est. completion 2021-10 2 sites
    Other conditions: Therapeutic Drug Monitoring, Subarachnoid Hemorrhage, Intracerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT04213313

    Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis

    Second Affiliated Hospital, Zhejiang University, School of Medicine 145 participants Est. completion 2019-06-30 1 site
    Other conditions: Infectious Keratitis
    View official trial listing →
  • Status unknown NCT NCT04225780

    Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection

    Not yet reported, Not yet reported Peking University People's Hospital 10 participants Est. completion 2021-03-30 Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT04278547

    Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response

    Not yet reported Hospital Universitari de Bellvitge 188 participants Est. completion 2023-03-25 1 site Stand-alone
    Other conditions: Heart Transplant Infection, CMV Infection
    View official trial listing →
  • Completed NCT NCT04478474

    Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients

    New York Medical College 100 participants Est. completion 2022-09-15 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT04577066

    Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.

    Not yet reported, Not yet reported Leiden University Medical Center 43 participants Est. completion 2022-12-22 1 site
    Other conditions: Plasmodium Falciparum Malaria
    View official trial listing →
  • Completed NCT NCT04690933

    AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients

    University Hospital, Limoges 400 participants Est. completion 2025-11-30 16 sites
    Other conditions: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Antivirals, Antiviral Drug Resistance
    View official trial listing →
  • Terminated NCT NCT04706507

    Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis

    Not yet reported Fred Hutchinson Cancer Center 205 participants Est. completion 2025-04-08 20 sites Stand-alone
    Other conditions: Acute Respiratory Failure
    View official trial listing →
  • Completed NCT NCT04724447

    ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

    Not yet reported, Not yet reported Laureate Institute for Brain Research, Inc. 20 participants Est. completion 2026-04-01 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT04919746

    Change in Dielectric Constant, Elasticity and Temperature by Acupuncture

    Not yet reported University of Sao Paulo 360 participants Est. completion 2022-12-01
    Other conditions: Acupuncture
    View official trial listing →
  • Terminated NCT NCT05011058

    An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas

    Not yet reported Viracta Therapeutics, Inc. 102 participants Est. completion 2025-01-31 62 sites
    Other conditions: Epstein-Barr Virus Associated Lymphoma, EBV-Positive DLBCL, NOS, EBV-Related Non-Hodgkin Lymphoma, EBV Related PTCL, NOS, EBV-Related Hodgkin Lymphoma, EBV-Related PTLD, EBV-Related Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT05041426

    Letermovir for CMV Prevention After Lung Transplantation

    Not yet reported Fernanda P Silveira, MD, MS 15 participants Est. completion 2025-03-03 1 site
    Other conditions: Lung Transplant, CMV
    View official trial listing →
  • Terminated NCT NCT05166577

    Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC

    Not yet reported Viracta Therapeutics, Inc. 26 participants Est. completion 2025-01-10 13 sites
    Obstructive sleep apnea Other conditions: Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV Related Carcinoma, EBV-Related Sarcoma
    View official trial listing →
  • Completed NCT NCT05238220

    Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients

    Piedmont Healthcare 37 participants Est. completion 2022-06-30 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Terminated NCT NCT05370976

    Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

    Not yet reported University Hospital, Lille 2 participants Est. completion 2023-08-24 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT05468606

    Coadministration of GA2 Sporozoites With Adjuvants

    Not yet reported Leiden University Medical Center 45 participants Est. completion 2024-12 1 site
    Other conditions: Malaria,Falciparum
    View official trial listing →
  • Completed NCT NCT05578820

    Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

    Not yet reported Gene Surgery LLC 21 participants Est. completion 2024-04-11 4 sites Stand-alone
    Other conditions: Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms
    View official trial listing →
  • Completed NCT NCT06034925

    Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

    Not yet reported Medical University of South Carolina 70 participants Est. completion 2025-08-30 1 site
    Other conditions: Transplant Complication, CMV
    View official trial listing →
  • Not yet recruiting NCT NCT06057194

    Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

    Not yet reported Maimónides Biomedical Research Institute of Córdoba 90 participants Est. completion 2027-04 1 site Stand-alone
    Other conditions: Infections, Cytomegalovirus
    View official trial listing →
  • Not yet recruiting NCT NCT06293339

    Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

    Not yet reported Leiden University Medical Center 14 participants Est. completion 2025-09-30
    Other conditions: Malaria,Falciparum
    View official trial listing →
  • Terminated NCT NCT06302140

    A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

    Not yet reported Viracta Therapeutics, Inc. 8 participants Est. completion 2025-01-15 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Status unknown NCT NCT06341686

    Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection

    Not yet reported Hospital do Rim e Hipertensão 100 participants Est. completion 2025-05
    Other conditions: CMV Infection
    View official trial listing →
  • Terminated NCT NCT06391918

    Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

    Not yet reported GenVivo, Inc. 37 participants Est. completion 2026-03-01 7 sites
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Completed NCT NCT06439342

    A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

    Not yet reported Takeda 20 participants Est. completion 2026-07-22 11 sites
    Other conditions: Cytomegalovirus (CMV)
    View official trial listing →
  • Active, not recruiting NCT NCT06474416

    A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

    Not yet reported Shanghai BDgene Co., Ltd. 16 participants Est. completion 2026-03-13 3 sites
    Other conditions: Herpes Simplex Virus Type I Stromal Keratitis
    View official trial listing →
  • Completed NCT NCT06757907

    Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis

    Not yet reported Al-Azhar University 20 participants Est. completion 2024-12-25 1 site
    Other conditions: Herpetic Keratitis
    View official trial listing →
  • Not yet recruiting NCT NCT06971913

    Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

    Not yet reported Peking University People's Hospital 100 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: SLE (Systemic Lupus), CMV
    View official trial listing →
  • Not yet recruiting NCT NCT07138989

    EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 10 participants Est. completion 2031-08-18 1 site
    Other conditions: Nasopharyngeal Cancinoma (NPC)
    View official trial listing →
  • Not yet recruiting NCT NCT07379203

    ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse

    Not yet reported Wits Health Consortium (Pty) Ltd 130 participants Est. completion 2027-06-30
    Other conditions: Cytomegalovirus (CMV) Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07450365

    Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection

    Not yet reported Hu Bofei 150 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Congenital CMV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07513623

    Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

    Not yet reported University of California, San Francisco 117 participants Est. completion 2032-10-31 6 sites
    Other conditions: Cytomegalovirus (CMV), Anterior Uveitis, Infectious Uveitis, CMV Infection
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ganciclovir Sodium, Ganciclovir, BW 759U, BW-B759U

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.